Sat.Nov 23, 2024

article thumbnail

Weekly Roundup – November 23, 2024

Healthcare IT Today

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week. A Look at Epic Culture and Interoperability with Brendan Keeler. The former Epic employee, now at HTD Health, talked to John Lynn for more than two hours.

article thumbnail

Health IT Product News Report November 2024

HealthIT Answers

Health IT product news from SPRY Therapeutics, NextGen Healthcare, Verbal, HIMSS, Luma Health, Mila Health, MedAdvisor Solutions, ixlayer, SoundHealth, Oracle Health, Verato, athenahealth, SmarterDx, Adobe Population Health and more. The post Health IT Product News Report November 2024 appeared first on Health IT Answers.

59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Measures for Recreational Marijuana Failed in Three States: a Win for Public Health

Bill of Health

by Katherine Drabiak The Outcome of Recreational Marijuana Ballot Measures Recreational marijuana was on the ballot in three states — Florida, North Dakota, and South Dakota. None of these three measures passed. Currently, 38 states and Washington D.C. allow medical marijuana, and 24 states and D.C. allow recreational marijuana. Marijuana is still classified as a Schedule I controlled substance , which means it is illegal to possess, sell or distribute, although the FDA has approved several puri

article thumbnail

Johns Hopkins surgeon Makary is Trump’s pick to lead FDA

Healthcare Dive

A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

FDA 301
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!